Compare JNJ & MA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JNJ | MA |
|---|---|---|
| Founded | 1886 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 449.6B | 482.1B |
| IPO Year | 1944 | 2006 |
| Metric | JNJ | MA |
|---|---|---|
| Price | $208.76 | $566.71 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 26 |
| Target Price | $205.07 | ★ $649.92 |
| AVG Volume (30 Days) | ★ 9.0M | 2.9M |
| Earning Date | 01-21-2026 | 01-29-2026 |
| Dividend Yield | ★ 2.50% | 0.61% |
| EPS Growth | ★ 71.26 | 18.23 |
| EPS | 10.35 | ★ 15.64 |
| Revenue | ★ $92,149,000,000.00 | $31,474,000,000.00 |
| Revenue This Year | $6.60 | $19.85 |
| Revenue Next Year | $5.28 | $12.61 |
| P/E Ratio | ★ $20.13 | $36.20 |
| Revenue Growth | 5.08 | ★ 15.60 |
| 52 Week Low | $140.68 | $465.59 |
| 52 Week High | $215.19 | $601.77 |
| Indicator | JNJ | MA |
|---|---|---|
| Relative Strength Index (RSI) | 59.96 | 59.01 |
| Support Level | $199.91 | $563.04 |
| Resistance Level | $215.19 | $571.76 |
| Average True Range (ATR) | 3.69 | 9.87 |
| MACD | -0.20 | 2.92 |
| Stochastic Oscillator | 58.05 | 80.76 |
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Mastercard is the second-largest payment processor in the world, having processed close to $10 trillion in volume during 2024. Mastercard operates in over 200 countries and processes transactions in over 150 currencies.